NASDAQ:CMRX
Chimerix Stock News
$0.95
+0.0027 (+0.284%)
At Close: May 03, 2024
Chimerix (CMRX) Stock: Why The Prise Rose Over 11% Today
07:01am, Monday, 23'rd May 2022
The stock price of Chimerix Inc (NASDAQ: CMRX) increased by over 11% pre-market today. This is why.
Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market
10:11pm, Friday, 20'th May 2022 PennyStocks
Are these biotech penny stocks on your watchlist right now?
The post Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market appeared first on Penny Stocks to Buy, Picks, News and Information
6 Stocks To Watch Amid Monkeypox Outbreak
09:08pm, Friday, 20'th May 2022 Benzinga
A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts.
What's going on? Monkeypox, a relative to smallpox, is a
Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market
06:11pm, Friday, 20'th May 2022
Are these biotech penny stocks on your watchlist right now? The post Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market appeared first on Penny Stocks to Buy, Picks, News and Information
6 Stocks To Watch Amid Monkeypox Outbreak
05:14pm, Friday, 20'th May 2022
A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts. What's going on?
Monkeypox Fears Drive Smallpox Antiviral Makers Higher
12:38pm, Friday, 20'th May 2022 Zacks Investment Research
Emergent BioSolutions (EBS) stock was up almost 12% while SIGA Technologies (SIGA) rose 17.1% on Thursday.
Monkeypox Fears Drive Smallpox Antiviral Makers Higher
09:47am, Friday, 20'th May 2022
Emergent BioSolutions (EBS) stock was up almost 12% while SIGA Technologies (SIGA) rose 17.1% on Thursday.
Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates
03:41pm, Wednesday, 18'th May 2022 Zacks Investment Research
Regulatory updates and acquisition news from Bristol Myers' (BMY) and BridgeBio Pharma (BBIO) are a few key highlights from the biotech sector during the past week.
Chimerix to Present at H.C. Wainwright Global Investment Conference
08:15pm, Tuesday, 17'th May 2022 GlobeNewswire Inc.
DURHAM, N.C., May 17, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patient
Chimerix to Present at H.C. Wainwright Global Investment Conference
04:15pm, Tuesday, 17'th May 2022
DURHAM, N.C., May 17, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients
Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates
01:08pm, Tuesday, 17'th May 2022 Zacks Investment Research
The development of Chimerix's (CMRX) lead candidate, ONC201, gets delayed as the FDA states that data from the retrospective study is unlikely to support an approval. The company ends the DSTAT progra
Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates
10:32am, Tuesday, 17'th May 2022
The development of Chimerix's (CMRX) lead candidate, ONC201, gets delayed as the FDA states that data from the retrospective study is unlikely to support an approval. The company ends the DSTAT progra
Chimerix (CMRX) Q1 2022 Earnings Call Transcript
06:00pm, Monday, 16'th May 2022 The Motley Fool
CMRX earnings call for the period ending March 31, 2022.
Here's Why Chimerix Stock Is Imploding Today
02:59pm, Monday, 16'th May 2022 The Motley Fool
Investors are furious about management's plan to sell its most valuable asset in order to chase a lackluster oncology program.
JetBlue Goes Hostile on Spirit, but This Biopharma's Getting Hit Hard
01:11pm, Monday, 16'th May 2022 The Motley Fool
The market looked prepared for a quiet open on Monday.
